Clinical Trials Logo

Clinical Trial Summary

Recent studies showed the therapeutic benefit of lymphadenectomy in advanced stage urothelial carcinoma of the upper urinary tract, but there is still a lack of prospective studies. Thus, the current guideline recommends lymph node dissection for invasive upper tract urothelial carcinoma (UTUC) on the basis of insufficient evidence. Also, the preoperative judgment of muscle invasive pathological stage T 2+,or N+ is difficult from preoperative imaging. In the investigators' clinical practice, the surgeons performed dissection of regional lymph nodes only in patients with enlargement of lymph nodes found in preoperative imaging or during surgery. The aim of this multi-institutional study was to examine the role of lymphadenectomy in urothelial carcinoma of the upper urinary tract.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03474926
Study type Interventional
Source RenJi Hospital
Contact jiwei huang, M.D.
Phone 8613651682825
Email huangjiwei@renji.com
Status Recruiting
Phase Phase 2
Start date February 22, 2018
Completion date February 22, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04973475 - Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer Phase 2
Completed NCT05829707 - Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia Phase 4
Completed NCT02476357 - A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection N/A
Recruiting NCT03230201 - Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) N/A
Recruiting NCT03845647 - Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. N/A